4-Methoxylonchocarpin protects against cisplatin induced acute kidney injury via regulating ferroptosis
These findings suggest that 4ML as a promising therapeutic agent for cisplatin-induced AKI, primarily through inhibiting ferroptosis and regulating AMPK. This study provides further evidence supporting the potential of traditional Chinese medicine-derived compounds in the management of AKI.
Authors
- Baodong Wang (ORCID: https://orcid.org/0000-0002-1323-1372)
- Nan Jiao (ORCID: https://orcid.org/0000-0002-5055-2159)
- Qiong Zhang (ORCID: https://orcid.org/0000-0001-9034-682X)
- Yuxiang Liu
- Fen Zhao (ORCID: https://orcid.org/0000-0001-5643-4260)
Institutions
- Shanxi Medical University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1080/0886022x.2025.2545941
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00